Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 164.00 | 114.75 | 1.4292 | 2.3539 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 71.09 | 110.00 | 114.75 | 0.9586 | 0.8813 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 71.09 | 45.00 | 114.75 | 0.3922 | -0.4842 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 126.00 | 114.75 | 1.0980 | 1.2900 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 289.00 | 278.25 | 1.0386 | 1.0906 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 396.00 | 278.25 | 1.4232 | 2.0204 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 153.73 | 405.00 | 278.25 | 1.4555 | 2.1008 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 226.00 | 278.25 | 0.8122 | 0.5686 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 247.00 | 278.25 | 0.8877 | 0.7402 |
| BT-20 | Lapatinib | 10 | uM | 9 | 312.50 | 153.73 | 119.00 | 278.25 | 0.4277 | -0.2585 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 282.00 | 278.25 | 1.0135 | 1.0315 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 312.50 | 153.73 | 395.00 | 278.25 | 1.4196 | 2.0115 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 321.00 | 278.25 | 1.1536 | 1.3634 |
| BT-20 | Lapatinib | 1 | uM | 9 | 312.50 | 153.73 | 327.00 | 278.25 | 1.1752 | 1.4151 |
| BT-20 | Linsitinib | 10 | uM | 9 | 312.50 | 153.73 | 282.00 | 278.25 | 1.0135 | 1.0315 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 356.00 | 278.25 | 1.2794 | 1.6671 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 251.00 | 278.25 | 0.9021 | 0.7731 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 282.00 | 278.25 | 1.0135 | 1.0315 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 332.00 | 278.25 | 1.1932 | 1.4583 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 312.50 | 153.73 | 114.00 | 278.25 | 0.4097 | -0.2948 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 258.00 | 278.25 | 0.9272 | 0.8310 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 312.50 | 153.73 | 287.00 | 278.25 | 1.0314 | 1.0737 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 287.00 | 278.25 | 1.0314 | 1.0737 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 153.73 | 193.00 | 278.25 | 0.6936 | 0.3045 |
| BT-20 | Linsitinib | 1 | uM | 9 | 312.50 | 153.73 | 262.00 | 278.25 | 0.9416 | 0.8642 |